With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

A federal appeals court upheld Friday an injunction preventing Apotex Corp. from selling its generic version of Plavix, a blockbuster blood thinner marketed by Bristol-Myers Squibb and Sanofi-Aventis.

In addition, there were no significant differences between the drug groups in the percent of patients who died or were hospitalized for any reason; had a stroke or transient ischemic attack ; or who ...

The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the ...

NEW YORK, Jan 22 (Reuters) - A lawyer for Sanofi-Aventis and Bristol-Myers Squibb Co. urged a U.S. judge to uphold the patent on blockbuster anti-clotting medication Plavix on Monday, as a high-stakes ...

How the influx of generics is bad for drug makers but good for you. July 25, 2011— -- intro: Ten of the world's top-selling prescription drugs are about to get cheaper. Over the next 17 months, ...

AP - The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, ...

NEW YORK — An economics professor at the Massachusetts Institute of Technology testified Monday that there will be “significant price erosion” in the drug Plavix, even if a federal judge grants a ...

A former senior vice-president at Bristol-Myers Squibb has been charged by the US Department of Justice with lying to federal authorities over a deal struck with rival generics maker Apotex. According ...